Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Response to Kujawa et al. letter-to-the-editor.

Sethuraman G, Taylor CC, Enerson M, Dunayevich E.

Schizophr Res. 2006 May;84(1):172-3. Epub 2006 Mar 24. No abstract available.

PMID:
16563702
2.

[The evaluation of long-term treatment with antipsychotics].

Millet B.

Encephale. 2006 Dec;32 Pt 3:S1072-5. Review. French. No abstract available.

PMID:
17356502
3.

[Letter to the editor].

Román González N, Quintana Holgado A, Himénez Hernández MP.

Farm Hosp. 2013 Jan-Feb;37(1):75-6. doi: 10.7399/FH.2013.37.1.93. Spanish. No abstract available.

4.

An early improvement threshold to predict response and remission in first-episode schizophrenia.

Schennach-Wolff R, Seemüller FH, Mayr A, Maier W, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Häfner H, Sauer H, Schneider F, Gaebel W, Jäger M, Möller HJ, Riedel M.

Br J Psychiatry. 2010 Jun;196(6):460-6. doi: 10.1192/bjp.bp.109.069328.

5.

[Cognitive functions and remission].

Sarfati Y.

Encephale. 2005 Dec;31 Pt 2:S21-3. French. No abstract available.

PMID:
16462631
6.

Should the CATIE study be a wake-up call?

Ragins M.

Psychiatr Serv. 2005 Dec;56(12):1489. No abstract available.

PMID:
16339608
7.

Response to Shen J, Kobak K, Zhao Y, et al. Use of remote centralized raters via live 2-way video ina multicenter clinical trial for schizophrenia. (J Clin Psychopharmacol. 2008;28:691-693).

Grunze HC, Höschl C, Montgomery SA, Sartorius N, Vieta E.

J Clin Psychopharmacol. 2009 Aug;29(4):409; author reply 409-10. doi: 10.1097/JCP.0b013e3181ace863. No abstract available.

PMID:
19593194
8.

Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.

Leucht S, Davis JM, Engel RR, Kissling W, Kane JM.

Acta Psychiatr Scand Suppl. 2009;(438):7-14. doi: 10.1111/j.1600-0447.2008.01308.x. Review. Erratum in: Acta Psychiatr Scand Suppl. 2011 Jul;124(1):82.

PMID:
19132961
9.

[Criteria of remission in schizophrenia].

Gorwood P.

Encephale. 2005 Dec;31 Pt 2:S18-20. French. No abstract available.

PMID:
16462630
10.

A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials.

Schennach-Wolff R, Möller HJ, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Riedel M.

Pharmacopsychiatry. 2010 Nov;43(7):245-51. doi: 10.1055/s-0030-1262788. Epub 2010 Oct 6.

PMID:
20927697
11.

Optimizing pharmacotherapy to maximize outcome in schizophrenia.

Fusion Medical Education LLC.

J Clin Psychiatry. 2005 Jan;66(1):122-33. No abstract available.

PMID:
15669898
12.

Schizophrenia: recent advances in psychopharmacology.

Sharma T.

Br J Hosp Med. 1996 Feb 21-Mar 5;55(4):194-8. Review. No abstract available.

PMID:
8777500
13.

Treatment of schizophrenia.

Keks NA, Kulkarni J, Copolov DL.

Med J Aust. 1989 Oct 16;151(8):462-7. Review. No abstract available.

PMID:
2574412
14.

[Maintenance pharmacotherapy of schizophrenia: remission and the effectiveness of long-acting risperidone therapy].

Sárosi A.

Neuropsychopharmacol Hung. 2006 Dec;8(4):179-87. Review. Hungarian.

PMID:
17211053
15.

Myth and reality of pragmatic trials.

Mohr P, Bitter I, Constant E, Jakovljević M, Jarema M, Pecenak J, Seifritz E, Svestka J, Sartorius N.

Psychiatr Danub. 2010 Mar;22(1):2-3. No abstract available.

16.

New developments in the treatment of schizophrenia.

CME Institute of Physicians Postgraduate Press, Inc.

J Clin Psychiatry. 2007 Mar;68(3):463-78. No abstract available.

PMID:
17388719
17.

Drug treatments for schizophrenia.

Adams C, Wilson P, Gilbody S, Bagnall AM, Lewis R.

Qual Health Care. 2000 Mar;9(1):73-9. Review. No abstract available.

18.

Seventeen-year clinical outcome of schizophrenia in Bali.

Kurihara T, Kato M, Reverger R, Tirta IG.

Eur Psychiatry. 2011 Jul-Aug;26(5):333-8. doi: 10.1016/j.eurpsy.2011.04.003. Epub 2011 Jun 22.

PMID:
21696927
19.

Study shows newer schizophrenia treatments no more effective than old.

Frantz S.

Nat Rev Drug Discov. 2005 Nov;4(11):872-3. No abstract available.

PMID:
16299914
20.

Improvement of schizophrenia negative and positive symptoms with amantadine as add-on therapy to antipsychotics: a case series.

Gama CS, Lucena DD, Cruz C, Lobato MI, Belmonte-de-Abreu PS.

Rev Bras Psiquiatr. 2010 Jun;32(2):193-4. No abstract available.

Supplemental Content

Support Center